![Benny Sorensen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Benny Sorensen
Directeur Général chez
HEMAB THERAPEUTICS HOLDINGS, INC.
Fortune : - $ au 31/08/2026
Profil
Benny Sorensen is Chief Executive Officer & Director at Hemab ApS since 2020.
Dr. Sorensen is President, Chief Executive Officer & Director at Hemab Therapeutics Holdings, Inc. since 2021.
Former roles include Global Medical Director at Baxter Healthcare Corp., Medical Director-Clinical Research at Alnylam Pharmaceuticals, Inc. from 2015 to 2016, and Senior Vice President-Strategic Projects at Codiak BioSciences, Inc. in 2021.
Education includes a doctorate from the University of Aarhus.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/05/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de Benny Sorensen
| Sociétés | Poste | Début |
|---|---|---|
| HEMAB THERAPEUTICS HOLDINGS, INC. | Directeur Général | 01/07/2021 |
Hemab ApS
 Hemab ApS BiotechnologyHealth Technology Develops antibodies for the treatment of rare bleeding disorders | Directeur Général | 22/07/2021 |
Anciens postes connus de Benny Sorensen
| Sociétés | Poste | Fin |
|---|---|---|
| CODIAK BIOSCIENCES | Directeur Technique/Scientifique/R&D | 10/05/2021 |
| ALNYLAM PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/10/2016 |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Directeur Technique/Scientifique/R&D | - |
Formation de Benny Sorensen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
51
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Health Technology |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
University of Aarhus
 University of Aarhus Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Codiak BioSciences, Inc.
 Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops exosome based therapeutics | Health Technology |
Hemab ApS
Hemab ApS BiotechnologyHealth Technology Develops antibodies for the treatment of rare bleeding disorders | Health Technology |
HEMAB THERAPEUTICS INC.
 HEMAB THERAPEUTICS INC. BiotechnologyHealth Technology Engages in research and development of prophylactic therapeutics for bleeding disorders | Health Technology |
